The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients – case reports and literature reviews

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2710|40|2|240-244

ISSN: 0269-4727

Source: JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.40, Iss.2, 2015-04, pp. : 240-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content